Treatment Approaches in 2L for mTNBC

 

Insights from 2023 ASCO® Annual Meeting
Avatar

ASCO® 2023 Insights: "Neoadjuvant Therapy in TNBC - Where We Are and What's Next?"

By Insights from 2023 ASCO® Annual Meeting FEATURING Erica Stringer-Reasor
By Insights from 2023 ASCO® Annual Meeting FEATURING Erica Stringer-Reasor
368 views
June 15, 2023
0 Comments
Login to view comments. Click here to Login
Treatment Approaches in 2L for mTNBC
14:40
PrecisCa

Expert Panel Case Discussion: 59 y/o With Stage 4 TNBC

Feat. R. L. Mahtani, W. Gradishar, J. O'Shaughnessy
08:53
UNC Lineberger Comprehensive Cancer Center

Sacituzumab Govitecan in 2L Therapy for mTNBC

Feat. L. Carey
07:12
Isabel Pimentel

Role of ctDNA in Early TNBC: Ready for Prime Use?

09:24
The University of Kansas Cancer Center

Treatment Sequence in mTNBC

Feat. P. Sharma
07:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "The X-7/7 Randomized Trial - Fixed Dose C…

Feat. C. Bohnenkamp
06:17
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results From the Randomized Phase 3 OLIGO…

Feat. A. Van Ommen - Nijhof
23:03
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Neoadjuvant Therapy in TNBC - Where We Ar…

Feat. E. Stringer-Reasor
19:34
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Clinical Impact of Evolving ADC Technology

Feat. H. McArthur
16:08
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Tailoring Post-Neoadjuvant Therapy in TNB…

Feat. H. Han
29:31
Community Oncology Alliance

Current Advances: Triple Negative & Locally Advanced Breast Canc…

Feat. E. Hamilton
27:50
Andrew McKenzie

Biomarker Testing in TNBC: Who, What, When, Where, and How?